Literature DB >> 34023209

Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.

Alexander Coltoff1, Andrew Bomback2, Shayan Shirazian2, Suzanne Lentzsch1, Divaya Bhutani3.   

Abstract

Entities:  

Keywords:  C3 glomerulopathyMonoclonal gammopathy of renal significance; Cd38; Myeloma; Plasma cells; Targeted therapy

Mesh：

Substances：

Year:  2021        PMID： 34023209      PMCID： PMC9245370          DOI： 10.1016/j.clml.2021.04.011

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  13 in total

1.  C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

Authors:  Andrew S Bomback; Dominick Santoriello; Rupali S Avasare; Renu Regunathan-Shenk; Pietro A Canetta; Wooin Ahn; Jai Radhakrishnan; Maddalena Marasa; Paul E Rosenstiel; Leal C Herlitz; Glen S Markowitz; Vivette D D'Agati; Gerald B Appel
Journal:  Kidney Int       Date:  2018-01-06       Impact factor: 10.612

2.  Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

Authors:  Michel de Weers; Yu-Tzu Tai; Michael S van der Veer; Joost M Bakker; Tom Vink; Daniëlle C H Jacobs; Lukas A Oomen; Matthias Peipp; Thomas Valerius; Jerry W Slootstra; Tuna Mutis; Wim K Bleeker; Kenneth C Anderson; Henk M Lokhorst; Jan G J van de Winkel; Paul W H I Parren
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

3.  Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Authors:  Sophie Chauvet; Véronique Frémeaux-Bacchi; Florent Petitprez; Alexandre Karras; Laurent Daniel; Stéphane Burtey; Gabriel Choukroun; Yahsou Delmas; Dominique Guerrot; Arnaud François; Moglie Le Quintrec; Vincent Javaugue; David Ribes; Laurence Vrigneaud; Bertrand Arnulf; Jean Michel Goujon; Pierre Ronco; Guy Touchard; Frank Bridoux
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

Review 4.  An update to the pathogenesis for monoclonal gammopathy of renal significance.

Authors:  Chao Zuo; Yuge Zhu; Gaosi Xu
Journal:  Ann Hematol       Date:  2020-02-26       Impact factor: 3.673

5.  C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Authors:  Ladan Zand; Andrea Kattah; Fernando C Fervenza; Richard J H Smith; Samih H Nasr; Yuzhou Zhang; Julie A Vrana; Nelson Leung; Lynn D Cornell; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2013-04-26       Impact factor: 8.860

6.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

7.  Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

Authors:  Henk M Lokhorst; Torben Plesner; Jacob P Laubach; Hareth Nahi; Peter Gimsing; Markus Hansson; Monique C Minnema; Ulrik Lassen; Jakub Krejcik; Antonio Palumbo; Niels W C J van de Donk; Tahamtan Ahmadi; Imran Khan; Clarissa M Uhlar; Jianping Wang; A Kate Sasser; Nedjad Losic; Steen Lisby; Linda Basse; Nikolai Brun; Paul G Richardson
Journal:  N Engl J Med       Date:  2015-08-26       Impact factor: 91.245

8.  C3 glomerulopathy: consensus report.

Authors:  Matthew C Pickering; Vivette D D'Agati; Carla M Nester; Richard J Smith; Mark Haas; Gerald B Appel; Charles E Alpers; Ingeborg M Bajema; Camille Bedrosian; Michael Braun; Mittie Doyle; Fadi Fakhouri; Fernando C Fervenza; Agnes B Fogo; Véronique Frémeaux-Bacchi; Daniel P Gale; Elena Goicoechea de Jorge; Gene Griffin; Claire L Harris; V Michael Holers; Sally Johnson; Peter J Lavin; Nicholas Medjeral-Thomas; B Paul Morgan; Cynthia C Nast; Laure-Hélène Noel; D Keith Peters; Santiago Rodríguez de Córdoba; Aude Servais; Sanjeev Sethi; Wen-Chao Song; Paul Tamburini; Joshua M Thurman; Michael Zavros; H Terence Cook
Journal:  Kidney Int       Date:  2013-10-30       Impact factor: 10.612

9.  C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome.

Authors:  Isaac E Lloyd; Alexander Gallan; Hunter K Huston; Kalani L Raphael; Dylan V Miller; Monica P Revelo; Mazdak A Khalighi
Journal:  Clin Kidney J       Date:  2016-09-23

10.  Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.

Authors:  Lin-Lin Li; Zhi-Ying Li; Su-Xia Wang; Xiao-Juan Yu; Ying Tan; Yu Wang; Feng Yu; Ming-Hui Zhao
Journal:  BMC Nephrol       Date:  2019-12-10       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.